ENRUHE
PF-Atlas › Clinical Trials › NCT06510322

Sildenafil to Reduce Vascular Remodeling During Left Ventricular Assist Device Support

Sildenafil · Early Phase 1

Registry ID
NCT06510322
Phase
Early Phase 1
Status
Recruiting
Drug / intervention
Sildenafil
Sponsor
Montefiore Medical Center
Start
2025-03-12

About this trial

Sildenafil is evaluated in NCT06510322, a Early Phase 1 idiopathic pulmonary fibrosis study sponsored by Montefiore Medical Center. Current status: Recruiting.

View NCT06510322 on ClinicalTrials.gov →

Explore related

All Sildenafil trialsAll IPF trials

Related trials

sildenafil — NCT00359736Sildenafil — NCT00352482sildenafil — NCT00659529Sildenafil — NCT01194232Sildenafil — NCT02057458Sildenafil — NCT00981747
Medical disclaimer. This page summarizes public trial data for NCT06510322 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.